Camblong Jurgi 4
4 · SOPHiA GENETICS SA · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CEO Jurgi Camblong Sells 4,486 Shares
What Happened
- Jurgi Camblong, CEO of SOPHiA GENETICS (SOPH), sold 4,486 shares on May 19, 2026, for total proceeds of $20,658. The reported weighted-average price was $4.60 per share (range $4.54–$4.71). This was a sale (not a purchase) executed to satisfy tax withholding obligations tied to RSU vesting, and thus is a routine, non-discretionary disposition.
Key Details
- Transaction date: 2026-05-19; filing date: 2026-05-20 (appears timely).
- Price: weighted average $4.60; prices ranged from $4.54 to $4.71 across multiple trades.
- Shares sold: 4,486; proceeds: $20,658.
- Shares owned after transaction: not specified in the provided filing details.
- Notable footnotes:
- The sale was effected pursuant to a pre-established Rule 10b5-1(c) trading plan and was done to meet tax-withholding on RSUs (footnote F1).
- The reported price is a weighted average covering multiple trades; the filer can provide per-trade price breakdown on request (footnote F2).
Context
- Sales to cover tax withholding after RSU vesting are common and typically administrative rather than indicative of a CEO changing conviction in the company. The use of a Rule 10b5-1 plan indicates the trades were pre-arranged and non-discretionary.
Insider Transaction Report
Form 4
Camblong Jurgi
DirectorExecutive Chairman
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-05-19$4.60/sh−4,486$20,658→ 3,629,495 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.71, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in- Fact for Jurgi Camblong|2026-05-20